Find Clinical Trials | Cedars-Sinai

165 results found

Non-Hodgkin Lymphoma, Other Hematopoietic

Zanubrutinib in Mantle Cell Lymphoma

This study focuses on individuals who have mantle cell lymphoma, which is a type of non-Hodgkin lymphoma. Zanubrutib is a drug approved by the U.S. Food and Drug Administration (FDA) for use in mantle cell ...

Hodgkin Lymphoma, Leukemia, not otherwise specified, Leukemia, other, Lymphoid Leukemia ...

Collecting and Combining Autologous Hematopoietic Stem Cells With (CAR) T-Cell Therapy in Hematological Malignancies

The purpose of this study is to assess the impact of adding blood stem cells to CAR T-cell therapy in an effort to improve cancer treatment. CAR T-cell therapy is a type of treatment in ...

Non-Hodgkin Lymphoma

IMPT-314 in Aggressive B-Cell Non-Hodgkin Lymphoma

The purpose of this study is to evaluate experimental gene-modified immune cells called IMPT-314 for the treatment of lymphomas that have either come back after treatment or have stopped responding to treatment. IMPT-314 is a ...

Anus, Brain and Nervous System, Breast, Cervix, Colon, Esophagus

LCB84 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumors

This study focuses on individuals who have metastatic cancer (cancer that has spread) that has not responded to standard treatments or for whom no effective therapy is available. The purpose of the study is to ...

Lung

Tepotinib with or Without Ramucirumab in Stage IV or Recurrent Non-Small Cell Lung Cancer

The purpose of this study is to determine whether the combination of 2 drugs, tepotinib and ramucirumab, lowers the chance of cancer growing or spreading in people with advanced non-small cell lung cancer. Researchers will ...